High Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis

BACKGROUND: Previous controlled trials are inconclusive regarding the efficacy of ursodeoxycholic acid (UDCA) for treating primary sclerosing cholangitis (PSC). METHODS: One hundred fifty adult patients with PSC were enrolled in a long-term, randomized, double-blind controlled trial of high-dose UDC...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lindor, Keith D., Kowdley, Kris V., Luketic, Velimir A. C., Harrison, M. Edwyn, McCashland, Timothy, Befeler, Alex S., Harnois, Denise, Jorgensen, Roberta, Petz, Jan, Keach, Jill, Mooney, Jody, Sargeant, Carol, Braaten, Julie, Bernard, Tamara, King, Debra, Miceli, Ellen, Schmoll, Jeff, Hoskin, Tanya, Thapa, Prabin, Enders, Felicity
פורמט: Artigo
שפה:Inglês
יצא לאור: 2009
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2758780/
https://ncbi.nlm.nih.gov/pubmed/19585548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.23082
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים